Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to Prasad Padala

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Padala, Prasad

PropertyValue
keywords Apathy
overview I have 19 years of experience in clinical and research management of neuropsychiatric symptoms of dementia with an emphasis on Apathy, a profound loss of motivation with far reaching consequences. I have conducted seven RCTs of apathy treatment. These studies were funded by the Department of Veterans Affairs, the National Institute of Aging and the Alzheimer’s Association. As the role of dopamine in management of apathy became clear to me, I have been instrumental in developing transcranial magnetic stimulation (rTMS) interventions for the same. My ongoing rTMS study, funded by a MERIT grant from the Department of Veterans Affairs, focuses on treating apathy in pre-dementia to test if such treatment influences the rates of conversion to dementia. Finally, I am a member of the Alzheimer’s Association’s Neuropsychiatric Syndrome Professional Interest Group, and the VA TMS providers group, the former setting the research agenda for apathy management and the latter providing innovative tool to achieve the same. I have served as a member on the Alzheimer’s Association research grants review committee, the Patient Centered Outcomes Research Institute (PCORI) reviewer, chair the RRD research panel at ORD and as an ad hoc reviewer for several journals focused on behavioral management of dementia.

One or more keywords matched the following items that are connected to Padala, Prasad

Item TypeName
Academic Article Treatment of apathy with methylphenidate.
Academic Article Modafinil therapy for apathy in an elderly patient.
Academic Article Methylphenidate for apathy and functional status in dementia of the Alzheimer type.
Academic Article Reversal of SSRI-associated apathy syndrome by discontinuation of therapy.
Academic Article Improvement of glycemic control using methylphenidate treatment of apathy: a preliminary report.
Academic Article The impact of apathy on glycemic control in diabetes: a cross-sectional study.
Academic Article Methylphenidate may treat apathy independent of depression.
Academic Article Role of apathy in the effectiveness of weight management programmes.
Academic Article Aripiprazole for Treatment of Apathy.
Academic Article Apathy associated with neurocognitive disorders: Recent progress and future directions.
Academic Article Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
Academic Article Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment: A double-blind, randomized, sham-controlled, cross-over pilot study.
Academic Article The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.
Academic Article Addressing Possible Effects of Sleep Apnea in a Study of Methylphenidate for Apathy in Alzheimer's Disease: Response to Kolla and Mansukhani.
Grant Apathy in Dementia Methylphenidate Trial (ADMET II)
Grant Apathy in Dementia Methylphenidate Trial (ADMET II)
Academic Article Improvement of neuronal integrity with methylphenidate treatment for apathy in Alzheimer's disease.
Academic Article Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
Academic Article Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
Academic Article Selective serotonin reuptake inhibitors-associated apathy syndrome: A cross sectional study.
Academic Article Neuromodulation for Apathy in Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study.
Grant The Role of Apathy in Self-management of Diabetes
Grant Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Grant Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Grant Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer’s Dementia
Grant Double blind placebo-controlled treatment trial of methylphenidate for the treatment of apathy in Alzheimer’s Dementia
Grant Immersive Virtual Reality for Apathy associated with Cognitive Impairment.
Grant A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Safety, Tolerability, And Pharmacodynamics Of CVL-871 In Subjects With Dementia-Related Apathy
Academic Article Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials.
Academic Article Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.
Academic Article Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).
Academic Article Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial.

Search Criteria
  • Apathy